1 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Development of Vascular-Disrupting Lymphocyte Therapy for Tumours (Antivessel-T-Cells)
Date du début: 1 août 2013, Date de fin: 31 juil. 2018,
T cell engineering with chimeric antigen receptors has opened the door to effective immunotherapy. CARs are fusion genes encoding receptors whose extracellular domain comprises a single chain variable fragment (scFv) antibody that binds to a tumour surface epitope, while the intracellular domain comprises the signalling module of CD3ζ along with powerful costimulatory domains (e.g. CD28 and/or 4-1 ...
Voir le projet